Takeaway
People carrying the autosomal dominant Alzheimer’s disease (ADAD) mutation have a higher frequency of motor symptoms than non-carriers, correlating with increased amyloid beta (Aβ) protein deposition in the basal ganglia.
Why this matters
The link between motor symptoms and ADAD mutations indicates clinical assessment of motor symptoms should be included in evaluation of individuals from families with a history of ADAD.